A new paradigm in therapeutic development is emerging as Remepy, a pioneering startup, successfully completed a Phase IIa clinical trial…
Read More
Yale Researchers Identify Key Proteins That Drive the Spread of Parkinson’s Disease Throughout the Brain
In a significant breakthrough for neurobiology, researchers at the Yale School of Medicine have identified two specific membrane proteins that…
Read More
Remepy’s Hybridopa, a Pioneer in AI-Driven Hybrid Drugs, Demonstrates Significant Efficacy in Parkinson’s Phase IIa Trial
San Francisco, CA – May 2026 – Remepy, a burgeoning health technology startup at the vanguard of integrating pharmaceutical and…
Read More
Yale Researchers Identify Key Proteins Responsible for the Spread of Parkinson’s Disease in the Brain
A groundbreaking study led by the Yale School of Medicine has identified two specific membrane proteins that act as a…
Read More
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
A new era in therapeutic innovation is dawning, marked by the successful Phase IIa clinical trial results for Hybridopa, an…
Read More
Tubulin Identified as a Critical Molecular Safeguard Against Neurodegenerative Protein Aggregation in Alzheimer’s and Parkinson’s Diseases
Scientists at the Baylor College of Medicine have announced a landmark discovery in the field of neurobiology, identifying a novel…
Read More
Long-Term Chlorpyrifos Exposure Linked to 2.5-Fold Increase in Parkinson’s Disease Risk UCLA Researchers Find
A groundbreaking study led by researchers at UCLA Health has established a definitive link between long-term residential exposure to the…
Read More
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
In a significant advancement for integrated medicine, Remepy, a pioneering startup, has announced successful Phase IIa clinical trial results for…
Read More
Baylor College of Medicine Researchers Identify Tubulin as a Key Protective Factor Against Alzheimer’s and Parkinson’s Disease Pathogenesis
In a landmark study that may redefine the therapeutic landscape for neurodegenerative disorders, scientists at Baylor College of Medicine have…
Read More
Long-Term Exposure to Agricultural Pesticide Chlorpyrifos Linked to 2.5-Fold Increase in Parkinson’s Disease Risk According to UCLA Health Study
A comprehensive investigation led by researchers at UCLA Health has established a definitive and alarming link between long-term residential exposure…
Read More
